Crossmark

Early diagnosis of melanoma: a randomized trial assessing the impact of the transmission of photographs taken with a smartphone from the general practitioner to the dermatologist on the time to dermatological consultation

Crossref DOI link: https://doi.org/10.1186/s12913-024-11106-9

Published Online: 2024-05-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bouton, Céline http://orcid.org/0000-0002-4946-4549
Schmeltz, Héloïse

Lévèque, Charlotte

Gaultier, Aurélie

Quereux, Gaëlle

Dreno, Brigitte

Nguyen, JM

Rat, Cédric http://orcid.org/0000-0003-4556-4494
License Information

Text and Data Mining valid from 2024-05-24

Version of Record valid from 2024-05-24
More Information

Article History

Received: 6 August 2023

Accepted: 13 May 2024

First Online: 24 May 2024

Declarations

:

: The OASE MELANOME protocol is in the field of Methodology Reference MR003, to which Nantes University Hospital conforms. All relevant laws of France and the European Union (EU) were followed. Participation by GPs and dermatologists was voluntary and was recorded via written informed consent. The GPs proposed participation to their patients. Patients were asked to sign a written informed consent form to allow their data to be used for research purposes. This study involved professionals and human participants and was approved by the Ethics Committee of the National College of Teaching General Practitioners (No. 1061721).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below